2026 Southeast Venture Showcase aims to turn research into real-world impact |
At this year’s Southeast Venture Showcase, hosted by Vanderbilt University and its Center for Technology Transfer and Commercialization, startups worked to secure the funding needed to move their ideas forward. Shoutout to the Vanderbilt-related startups at the showcase: COG Learning, ImageAssist, Kifa Therapeutics, Mobius AI, Neurodiverse Technologies, and Vasowatch.
|
|
|
Nissha Medical Technologies officially opens Engineering & Innovation Center of Excellence on Vanderbilt’s campus |
“By welcoming Nissha Medical Technologies directly onto Vanderbilt’s main campus—our first industry partner to be housed in this way—we are strengthening that connection in significant ways. We are creating the Nashville Innovation Center of Excellence, which is not just a building, but a thriving ecosystem that allows ideas to flourish and move from a whiteboard to a clinical trial with lightning speed,” Chancellor Daniel Diermeier said.
|
ICYMI: CTTC LUNCH & LEARN RECAP |
Essential Intellectual Property Information |
How do you protect your research while still publishing and advancing your work? In this session, Alan Bentley, Assistant Vice Chancellor for Technology Transfer & Intellectual Property Development, breaks down the fundamentals of intellectual property for scientists.
|
|
|
Vanderbilt brings national leaders together to explore quantum’s growing real-world impact |
Vanderbilt gathered leaders from academia, industry, and government to highlight how quantum technologies are rapidly moving and beginning to shape diverse sectors.
Learn more about the gathering
|
|
|
Driving Innovation Forward: CTTC's Annual Publication |
ICYMI: Read how VU and VUMC researchers are transforming research into real-world impact, driving economic growth locally and improving quality of life globally.
View publication
|
|
|
|
| CTTC FY26 Highlights (YTD) |
- Licenses & Options*: 230
- MTAs: 883
- CDAs: 29
- Invention Disclosures: 224
- U.S. Patents Issued: 53
|
* includes end-user software and materials licenses along with conventional technology licenses
|
|
|
|
INNOVATION ECOSYSTEM PARTNER SPOTLIGHT |
Brock Family Center for Applied Innovation |
The Brock Family Center for Applied Innovation supports investigators at Vanderbilt University Medical Center in advancing biomedical discoveries toward startup formation, commercialization, and external investment. Read more about the Brock Center
|
SAVE THE DATE: OPIOID USE & WORKFORCE HEALTH: POLICY, PREVENTION, AND RECOVERY SUMMIT |
Friday, June 5 from 9:00 a.m. to 4:00 p.m. in 214 Light Hall
The Brock Family Center for Applied Innovation and Goldfinch Health are hosting an opioid‑focused summit centered on the role employers play in prevention and recovery. The program will explore research and topics specific to opioid use policy, education, prevention, treatment, and recovery and is funded under a grant contract with the Tennessee Opioid Abatement Council.
|
Space-Edge Pre-Accelerator Showcase |
Space-Edge hosted its annual showcase, featuring researchers and founders from 16 space-enabled ventures pitching to investors, technical experts, and strategic leaders. Vanderbilt’s cohort stood out, with Aura Life Sciences earning the top prize from Rhodium Scientific and several other teams earning top marks from judges. Judges are selecting additional teams for exclusive pitch opportunities at the International Space Development Conference (ISDC) later this year. Learn more about SpaceEdge
|
Applied Drug Discovery & Development (AD3) Certificate Vanderbilt University’s Warren Center for Neuroscience Drug Discovery |
For those working in or adjacent to drug discovery, Vanderbilt has launched a new online Applied Drug Discovery & Development (AD3) Certificate through the Warren Center for Neuroscience Drug Discovery.
It’s designed to provide a practical understanding of how scientific discoveries move toward therapeutics; something that’s increasingly important across roles, from research to legal to investment. Learn more about the course
|
|
|
|
Five Vanderbilt Technologies Earn Patent Protection in April |
-
12,594,320 – “Method for Treating Checkpoint Inhibitors Induced Adverse Events” (Joe-Elie Salem, Yves Allenbach, Mathieu Kerneis, Javid Moslehi, Douglas Johnson)
-
12,600,726 – “Antagonists of the Muscarinic Acetylcholine Receptor M4” (Craig Lindsley, Thomas Bridges, Jeffrey Conn, Aaron Bender, Darren Engers)
-
12,611,142 – “Method and Apparatus for Intraoperative Nerve Visualization Using Polarized Diffuse Reflectance Spectroscopy and Applications of Same” (Justin Baba, Anita Mahadevan-Jansen, Graham Throckmorton)
-
12,611,227 – “Medical Device Delivery Apparatus and Method” (Kent Higdon)
-
12,613,322 – “Method and System Using Coded Excitation with Invertible Skew-Symmetric Binary Sequences and Inverse Filtering” (Emelina Prevost Vienneau, Brett Byram)
|
|
|
|
Center for Technology Transfer and Commercialization
2100 West End Ave. Suite 750
Nashville, TN 37203
vanderbilt.edu/cttc I 615.343.2430
|
2100 West End Ave Suite 750 | Nashville, TN 37203 US
|
|
|
|
|
